The present invention relates to a class of compounds represented by formula (I): (See Formula) or a pharmaceutically acceptable salt thereof; wherein A is (a) or (b) or (c) or (d): (See Formula) to pharmaceutical compositions thereof and to methods of using these compounds and those compositions as alphav beta3 integrin antagonists.